Chemours CO Form 4 insider transactions

Joseph T. Martinko, a Chemours Co officer, reports acquiring shares and stock options, according to a Form 4 filing.

Kristine Wellman, SVP, GC & Corp. Secretary of Chemours Co, reports the acquisition of common stock and stock options.

Chief Financial Officer of Chemours, Shane Hostetter, reports acquiring shares and stock options in the company.

Chief Accounting Officer David Will reports acquiring common stock and stock options in Chemours Co on March 3, 2025.

Alvenia Scarborough, SVP Corp Communications & CBO of Chemours Co, reports acquiring shares and stock options on March 3, 2025.

Damian Gumpel, President of Titanium Technologies at Chemours Co, reports the acquisition of common stock and stock options.

Director Joseph Daniel Kava acquired 2,886 shares of Chemours Co common stock on March 3, 2025, through restricted stock units.

Director Leslie M Turner acquired 2,886 shares of Chemours Co common stock on March 3, 2025.

Calderon Gerardo, a Chemours Co executive, reported a transaction involving the withholding of shares to cover tax obligations on vesting restricted stock units and dividend equivalent units.

Kristine M. Wellman, SVP, GC & Corp. Secretary of Chemours Co, reports disposition of shares to cover tax obligations related to vesting restricted stock units.

Diane I. Picho, Chief Enterprise Enablement Officer at Chemours Co, reports a transaction involving common stock to cover tax obligations on vesting restricted stock units and dividend equivalent units.

Alvenia Scarborough, SVP Corp Communications & CBO of Chemours Co, disposed of 875 shares of common stock on March 1, 2025, to cover tax obligations arising from vesting restricted stock units and dividend equivalent units.

Chemours CEO Denise Dignam reports a transaction involving common stock to cover tax obligations on vesting restricted stock units and dividend equivalent units.

Joseph T. Martinko, a Chemours Co officer, reports a transaction involving common stock to cover tax obligations.

Chemours director Alister Cowan purchased 10,200 shares of company stock at a weighted average price of $19.2619 per share.

A Chemours executive, Alvenia Scarborough, sold 7,500 shares of common stock at a weighted average price of $20.6361 per share.

David Will, Chief Accounting Officer of Chemours Co, reports acquiring 20,984 shares of common stock on August 12, 2024.

Diane I. Picho, Interim President of Titanium Technologies at Chemours Co, recently sold shares of common stock in multiple transactions.

Director Guillaume Pepy reported the acquisition of Chemours Co stock units and shares withheld for tax obligations.

Director Sean D Keohane reports acquiring 8,547 shares of Chemours Co common stock on August 6, 2024.

Director Dawn L. Farrell acquired 8,547 shares of Chemours Co common stock on August 6, 2024, at $0.00 per share.

Director Curt Anastasio reported acquiring 8,547 shares of Chemours Co common stock on August 6, 2024.

Director Mary B Cranston acquired 8,547 shares of Chemours Co common stock on August 6, 2024.

Director Pamela Fletcher reports acquiring 8,547 shares of Chemours common stock and disposing of shares, resulting in a total beneficial ownership of 10,015.9098 shares.

Director Satterthwaite Livingston reported acquiring 8,547 stock units of Chemours Co on August 6, 2024, which convert to common stock upon separation from the board.

Alister Cowan, a director of Chemours Co, reported acquiring 8,547 shares of common stock and now beneficially owns 11,226.4044 shares.

Director Kane Erin N reports acquiring 8,547 shares of Chemours Co common stock on August 6, 2024, bringing total holdings to 48,884.7398 shares.

Chemours' Chief Financial Officer, Shane Hostetter, acquired 26,709 shares of common stock on August 6, 2024, through a restricted stock unit award.

Kristine M Wellman, SVP, GC & Corp. Secretary of Chemours Co, disposed of 363 shares of common stock on August 1, 2024, to cover tax obligations related to vesting restricted stock units and dividend equivalent units.

Joseph T. Martinko, President, Thermal & Specialized Solutions at Chemours Co, reports disposition of shares to cover tax obligations on vested stock units.